Legal News

Pfizer?s General Counsel Steps Down

By Dan Slater

The GC churn continues at Pfizer. Citing personal reasons, the company announced this afternoon that Allen Waxman, who in 2006 replaced Jeffrey Kindler as the company’s general counsel, is leaving the company. Waxman (pictured) will remain outside counsel to Pfizer through an interim period, during which David Reid, currently a senior VP and managing director, will fill in as the temporary GC.

Back in August, 2006, Kindler, who transitioned from GC to CEO, labeled Waxman an “essential” element in Pfizer’s reorganized executive ranks.

Here’s a short bio of Waxman from Portfolio. Prior to joining Pfizer in 2003, Waxman spent nearly 15 years at Williams & Connolly in Washington, D.C. He graduated from Harvard Law School in 1987 and clerked for federal district judge Thomas Penfield Jackson, who became a household name during the Microsoft antitrust case.

Full post as published by Law Blog - WSJ.com on March 11, 2008 (boomark / email).